Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Donovan Joanne M., holds the title of CMO at Edgewise Therapeutics, Inc..
On 2026-11-16, the insider transacted 854 shares.The shares were transacted at a weighted average price of $45.48 per share, resulting in a total market-relevant value of $39K.
Donovan Joanne M. (CMO) sold $39K of $EWTX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.